{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T16:24:20Z","timestamp":1777566260634,"version":"3.51.4"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,8,17]],"date-time":"2016-08-17T00:00:00Z","timestamp":1471392000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003130","name":"Flemish Fonds voor Wetenschappelijk Onderzoek","doi-asserted-by":"crossref","award":["1509715N"],"award-info":[{"award-number":["1509715N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Pharmacology"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.coph.2016.08.003","type":"journal-article","created":{"date-parts":[[2016,8,27]],"date-time":"2016-08-27T02:15:11Z","timestamp":1472264111000},"page":"106-115","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":71,"special_numbering":"C","title":["Antiviral therapies on the horizon for influenza"],"prefix":"10.1016","volume":"30","author":[{"given":"Lieve","family":"Naesens","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annelies","family":"Stevaert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evelien","family":"Vanderlinden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.coph.2016.08.003_bib0330","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S1473-3099(12)70121-4","article-title":"Estimated global mortality associated with the first 12 months of 2009 pandemic influenza A H1N1 virus circulation: a modelling study","volume":"12","author":"Dawood","year":"2012","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.coph.2016.08.003_bib0335","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.antiviral.2015.02.003","article-title":"Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2013\u20132014","volume":"117","author":"Takashita","year":"2015","journal-title":"Antiviral Res"},{"key":"10.1016\/j.coph.2016.08.003_bib0340","first-page":"CD008965","article-title":"Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children","volume":"4","author":"Jefferson","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.coph.2016.08.003_bib0345","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1016\/S0140-6736(14)62449-1","article-title":"Oseltamivir treatment for influenza in adults: a meta-analysis of randomised controlled trials","volume":"385","author":"Dobson","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.coph.2016.08.003_bib0350","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S2213-2600(14)70041-4","article-title":"Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant data","volume":"2","author":"Muthuri","year":"2014","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.coph.2016.08.003_sbref0355","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.cmi.2014.11.020","article-title":"Neuraminidase inhibitors: who, when, where?","volume":"21","author":"Nguyen-Van-Tam","year":"2015","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.coph.2016.08.003_bib0360","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.tips.2009.03.002","article-title":"Emerging antiviral targets for influenza A virus","volume":"30","author":"Krug","year":"2009","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.coph.2016.08.003_bib0365","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.coviro.2015.08.008","article-title":"Influenza virus\u2013host interactomes as a basis for antiviral drug development","volume":"14","author":"Watanabe","year":"2015","journal-title":"Curr Opin Virol"},{"key":"10.1016\/j.coph.2016.08.003_bib0370","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1093\/infdis\/jis622","article-title":"A phase II study of DAS181, a novel host directed antiviral for the treatment of influenza infection","volume":"206","author":"Moss","year":"2012","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coph.2016.08.003_bib0375","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1126\/science.1232552","article-title":"Mechanism-based covalent neuraminidase inhibitors with broad-spectrum influenza antiviral activity","volume":"340","author":"Kim","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.coph.2016.08.003_bib0380","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/bip.22623","article-title":"Recent progress in designing inhibitors that target the drug-resistant M2 proton channels from the influenza A viruses","volume":"104","author":"Wang","year":"2015","journal-title":"Biopolymers"},{"key":"10.1016\/j.coph.2016.08.003_bib0385","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1021\/jm301538e","article-title":"Discovery of novel dual inhibitors of the wild-type and the most prevalent drug-resistant mutant, S31N, of the M2 proton channel from influenza A virus","volume":"56","author":"Wang","year":"2013","journal-title":"J Med Chem"},{"key":"10.1016\/j.coph.2016.08.003_bib0390","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1146\/annurev-immunol-032712-095916","article-title":"Broadly neutralizing antiviral antibodies","volume":"31","author":"Corti","year":"2013","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.coph.2016.08.003_sbref0395","first-page":"323","article-title":"Structural characterization of viral epitopes recognized by broadly cross-reactive antibodies","volume":"386","author":"Lee","year":"2015","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.coph.2016.08.003_bib0400","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1126\/science.1222908","article-title":"Highly conserved protective epitopes on influenza B viruses","volume":"337","author":"Dreyfus","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.coph.2016.08.003_bib0405","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1172\/JCI84428","article-title":"Broadly neutralizing anti-influenza antibodies require Fc receptor engagement for in vivo protection","volume":"126","author":"DiLillo","year":"2016","journal-title":"J Clin Invest"},{"key":"10.1016\/j.coph.2016.08.003_bib0410","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.chom.2014.04.009","article-title":"Broadly neutralizing influenza hemagglutinin stem-specific antibody CR8020 targets residues that are prone to escape due to host selection pressure","volume":"15","author":"Tharakaraman","year":"2014","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.coph.2016.08.003_bib0415","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1080\/19420862.2016.1167294","article-title":"Preclinical pharmacokinetics of MHAA4549A, a human monoclonal antibody to influenza A virus, and the prediction of its efficacious clinical dose for the treatment of patients hospitalized with influenza A","volume":"8","author":"Gupta","year":"2016","journal-title":"MAbs"},{"key":"10.1016\/j.coph.2016.08.003_bib0420","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.antiviral.2016.01.012","article-title":"Meeting report: 4th ISIRV antiviral group conference: novel antiviral therapies for influenza and other respiratory viruses","volume":"129","author":"McKimm-Breschkin","year":"2016","journal-title":"Antiviral Res"},{"key":"10.1016\/j.coph.2016.08.003_bib0425","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1016\/j.bbamem.2014.04.015","article-title":"Peptide entry inhibitors of enveloped viruses: the importance of interfacial hydrophobicity","volume":"1838","author":"Badani","year":"2014","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.coph.2016.08.003_bib0430","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/med.21289","article-title":"Emerging antiviral strategies to interfere with influenza virus entry","volume":"34","author":"Vanderlinden","year":"2014","journal-title":"Med Res Rev"},{"key":"10.1016\/j.coph.2016.08.003_bib0435","doi-asserted-by":"crossref","first-page":"17736","DOI":"10.1073\/pnas.0807142105","article-title":"Structure of influenza hemagglutinin in complex with an inhibitor of membrane fusion","volume":"105","author":"Russell","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coph.2016.08.003_bib0440","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S1473-3099(14)70717-0","article-title":"Effect of nitazoxanide in adults and adolescents with acute uncomplicated influenza: a double-blind, randomised, placebo-controlled, phase 2b\/3 trial","volume":"14","author":"Haffizulla","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.coph.2016.08.003_bib0445","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.antiviral.2014.07.014","article-title":"Nitazoxanide: a first-in-class broad-spectrum antiviral agent","volume":"110","author":"Rossignol","year":"2014","journal-title":"Antiviral Res"},{"key":"10.1016\/j.coph.2016.08.003_bib0450","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/nrmicro.2016.87","article-title":"Influenza virus RNA polymerase: insights into the mechanisms of viral RNA synthesis","volume":"14","author":"Te Velthuis","year":"2016","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.coph.2016.08.003_sbref0455","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/nature14008","article-title":"Structure of influenza A polymerase bound to the viral RNA promoter","volume":"516","author":"Pflug","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.coph.2016.08.003_sbref0460","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/nature14009","article-title":"Structural insight into cap-snatching and RNA synthesis by influenza polymerase","volume":"516","author":"Reich","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.coph.2016.08.003_sbref0465","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/nature15525","article-title":"Crystal structure of the RNA-dependent RNA polymerase from influenza C virus","volume":"527","author":"Hengrung","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.coph.2016.08.003_sbref0470","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.molcel.2015.11.016","article-title":"Influenza polymerase can adopt an alternative configuration involving a radical repacking of PB2 domains","volume":"61","author":"Thierry","year":"2016","journal-title":"Mol Cell"},{"key":"10.1016\/j.coph.2016.08.003_bib0475","doi-asserted-by":"crossref","DOI":"10.1002\/med.21401","article-title":"The influenza virus polymerase complex: an update on its structure, functions and significance for antiviral drug design","author":"Stevaert","year":"2016","journal-title":"Med Res Rev"},{"key":"10.1016\/j.coph.2016.08.003_bib0480","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.antiviral.2013.09.015","article-title":"Favipiravir (T-705), a novel viral RNA polymerase inhibitor","volume":"100","author":"Furuta","year":"2013","journal-title":"Antiviral Res"},{"key":"10.1016\/j.coph.2016.08.003_bib0485","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1128\/AAC.49.3.981-986.2005","article-title":"Mechanism of action of T-705 against influenza virus","volume":"49","author":"Furuta","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.coph.2016.08.003_bib0490","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1124\/mol.113.087247","article-title":"Role of human hypoxanthine guanine phosphoribosyltransferase in activation of the antiviral agent T-705 (favipiravir)","volume":"84","author":"Naesens","year":"2013","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.coph.2016.08.003_bib0495","doi-asserted-by":"crossref","first-page":"5202","DOI":"10.1128\/AAC.00649-13","article-title":"Mechanism of action of T-705 ribosyl triphosphate against influenza virus RNA polymerase","volume":"57","author":"Sangawa","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.coph.2016.08.003_bib0500","doi-asserted-by":"crossref","first-page":"e68347","DOI":"10.1371\/journal.pone.0068347","article-title":"The ambiguous base-pairing and high substrate efficiency of T-705 (favipiravir) ribofuranosyl 5\u2032-triphosphate towards influenza A virus polymerase","volume":"8","author":"Jin","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.coph.2016.08.003_bib0505","doi-asserted-by":"crossref","first-page":"3741","DOI":"10.1128\/JVI.02346-12","article-title":"T-705 (Favipiravir) induces lethal mutagenesis in influenza A H1N1 viruses in vitro","volume":"87","author":"Baranovich","year":"2013","journal-title":"J Virol"},{"key":"10.1016\/j.coph.2016.08.003_bib0510","doi-asserted-by":"crossref","first-page":"4794","DOI":"10.1038\/ncomms5794","article-title":"Generation and characterization of influenza A viruses with altered polymerase fidelity","volume":"5","author":"Cheung","year":"2014","journal-title":"Nat Commun"},{"key":"10.1016\/j.coph.2016.08.003_sbref0515","doi-asserted-by":"crossref","first-page":"6668","DOI":"10.1021\/jm5007275","article-title":"Discovery of a novel, first-in-class, orally bioavailable azaindole inhibitor (VX-787) of influenza PB2","volume":"57","author":"Clark","year":"2014","journal-title":"J Med Chem"},{"key":"10.1016\/j.coph.2016.08.003_bib0520","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/nsmb.1421","article-title":"The structural basis for cap binding by influenza virus polymerase subunit PB2","volume":"15","author":"Guilligay","year":"2008","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.coph.2016.08.003_bib0525","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1128\/AAC.04623-14","article-title":"Preclinical activity of VX-787, a first-in-class, orally bioavailable inhibitor of the influenza virus polymerase PB2 subunit","volume":"59","author":"Byrn","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.coph.2016.08.003_sbref0530","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1074\/jbc.M115.693051","article-title":"Molecular basis of mRNA cap recognition by influenza B polymerase PB2 subunit","volume":"291","author":"Xie","year":"2016","journal-title":"J Biol Chem"},{"key":"10.1016\/j.coph.2016.08.003_bib0535","doi-asserted-by":"crossref","first-page":"9141","DOI":"10.1074\/jbc.M115.636464","article-title":"The crystal structure of the PB2 cap-binding domain of influenza B virus reveals a novel cap recognition mechanism","volume":"290","author":"Liu","year":"2015","journal-title":"J Biol Chem"},{"key":"10.1016\/j.coph.2016.08.003_bib0540","doi-asserted-by":"crossref","first-page":"7504","DOI":"10.1128\/JVI.02375-10","article-title":"Recognition of cap structure by influenza B virus RNA polymerase is less dependent on the methyl residue than recognition by influenza A virus polymerase","volume":"85","author":"Wakai","year":"2011","journal-title":"J Virol"},{"key":"10.1016\/j.coph.2016.08.003_bib0545","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1038\/nature07745","article-title":"The cap-snatching endonuclease of influenza virus polymerase resides in the PA subunit","volume":"458","author":"Dias","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.coph.2016.08.003_bib0550","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1038\/nature07720","article-title":"Crystal structure of an avian influenza polymerase PA(N) reveals an endonuclease active site","volume":"458","author":"Yuan","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.coph.2016.08.003_bib0555","doi-asserted-by":"crossref","first-page":"e1002830","DOI":"10.1371\/journal.ppat.1002830","article-title":"Structural and biochemical basis for development of influenza virus inhibitors targeting the PA endonuclease","volume":"8","author":"DuBois","year":"2012","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coph.2016.08.003_bib0560","doi-asserted-by":"crossref","first-page":"e1002831","DOI":"10.1371\/journal.ppat.1002831","article-title":"Structural analysis of specific metal chelating inhibitor binding to the endonuclease domain of influenza pH1N1 (2009) polymerase","volume":"8","author":"Kowalinski","year":"2012","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coph.2016.08.003_bib0565","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1128\/AAC.38.12.2827","article-title":"Inhibition of cap (m7GpppXm)-dependent endonuclease of influenza virus by 4-substituted 2,4-dioxobutanoic acid compounds","volume":"38","author":"Tomassini","year":"1994","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.coph.2016.08.003_bib0570","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.antiviral.2007.12.010","article-title":"PA subunit of RNA polymerase as a promising target for anti-influenza virus agents","volume":"78","author":"Nakazawa","year":"2008","journal-title":"Antiviral Res"},{"key":"10.1016\/j.coph.2016.08.003_bib0575","doi-asserted-by":"crossref","first-page":"10524","DOI":"10.1128\/JVI.00832-13","article-title":"Mutational analysis of the binding pockets of the diketo acid inhibitor L-742,001 in the influenza virus PA endonuclease","volume":"87","author":"Stevaert","year":"2013","journal-title":"J Virol"},{"key":"10.1016\/j.coph.2016.08.003_bib0580","doi-asserted-by":"crossref","first-page":"3669","DOI":"10.1073\/pnas.1519772113","article-title":"Identification and characterization of influenza variants resistant to a viral endonuclease inhibitor","volume":"113","author":"Song","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coph.2016.08.003_bib0585","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1021\/cb400400j","article-title":"Crystallographic fragment screening and structure-based optimization yields a new class of influenza endonuclease inhibitors","volume":"8","author":"Bauman","year":"2013","journal-title":"ACS Chem Biol"},{"key":"10.1016\/j.coph.2016.08.003_bib0590","doi-asserted-by":"crossref","first-page":"19151","DOI":"10.1073\/pnas.1013592107","article-title":"High-throughput identification of compounds targeting influenza RNA-dependent RNA polymerase activity","volume":"107","author":"Su","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coph.2016.08.003_bib0595","doi-asserted-by":"crossref","first-page":"e1002668","DOI":"10.1371\/journal.ppat.1002668","article-title":"A novel small molecule inhibitor of influenza A viruses that targets polymerase function and indirectly induces interferon","volume":"8","author":"Ortigoza","year":"2012","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coph.2016.08.003_bib0600","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/nature07120","article-title":"Crystal structure of the polymerase PA(C)-PB1(N) complex from an avian influenza H5N1 virus","volume":"454","author":"He","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.coph.2016.08.003_bib0605","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1038\/nature07225","article-title":"The structural basis for an essential subunit interaction in influenza virus RNA polymerase","volume":"454","author":"Obayashi","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.coph.2016.08.003_bib0610","doi-asserted-by":"crossref","first-page":"6247","DOI":"10.1073\/pnas.1119817109","article-title":"Small molecule inhibitors of influenza A and B viruses that act by disrupting subunit interactions of the viral polymerase","volume":"109","author":"Muratore","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coph.2016.08.003_sbref0615","doi-asserted-by":"crossref","first-page":"3830","DOI":"10.1021\/acs.jmedchem.5b00012","article-title":"A broad anti-influenza hybrid small molecule that potently disrupts the interaction of polymerase acidic protein-basic orotein 1 (PA-PB1) subunits","volume":"58","author":"Massari","year":"2015","journal-title":"J Med Chem"},{"key":"10.1016\/j.coph.2016.08.003_bib0620","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.antiviral.2015.11.005","article-title":"Identification of a small-molecule inhibitor of influenza virus via disrupting the subunits interaction of the viral polymerase","volume":"125","author":"Yuan","year":"2016","journal-title":"Antiviral Res"},{"key":"10.1016\/j.coph.2016.08.003_bib0625","doi-asserted-by":"crossref","first-page":"e1005062","DOI":"10.1371\/journal.ppat.1005062","article-title":"A novel antiviral target structure involved in the RNA binding, dimerization, and nuclear export functions of the influenza A virus nucleoprotein","volume":"11","author":"Kakisaka","year":"2015","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coph.2016.08.003_bib0630","doi-asserted-by":"crossref","first-page":"15366","DOI":"10.1073\/pnas.1107906108","article-title":"Inhibition of influenza virus replication via small molecules that induce the formation of higher-order nucleoprotein oligomers","volume":"108","author":"Gerritz","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coph.2016.08.003_sbref0635","doi-asserted-by":"crossref","first-page":"21662","DOI":"10.1038\/srep21662","article-title":"Using mutagenesis to explore conserved residues in the RNA-binding groove of influenza A virus nucleoprotein for antiviral drug development","volume":"6","author":"Liu","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.coph.2016.08.003_bib0640","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1128\/AAC.02335-12","article-title":"Structure-based discovery of the novel antiviral properties of naproxen against the nucleoprotein of influenza A virus","volume":"57","author":"Lejal","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.coph.2016.08.003_bib0645","doi-asserted-by":"crossref","first-page":"10890","DOI":"10.1073\/pnas.1502374112","article-title":"A broadly neutralizing human monoclonal antibody is effective against H7N9","volume":"112","author":"Tharakaraman","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coph.2016.08.003_bib0650","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/nbt.1638","article-title":"Identification of influenza A nucleoprotein as an antiviral target","volume":"28","author":"Kao","year":"2010","journal-title":"Nat Biotechnol"}],"container-title":["Current Opinion in Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471489216300881?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471489216300881?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,9]],"date-time":"2018-09-09T00:24:44Z","timestamp":1536452684000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471489216300881"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":65,"alternative-id":["S1471489216300881"],"URL":"https:\/\/doi.org\/10.1016\/j.coph.2016.08.003","relation":{},"ISSN":["1471-4892"],"issn-type":[{"value":"1471-4892","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antiviral therapies on the horizon for influenza","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coph.2016.08.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}